2. Gene
  3. Cdk7 - cyclin-dependent kinase 7 Gene

Cdk7 - cyclin-dependent kinase 7 Gene

  • Gene
  • Protein
  • Agent
  • Ortholog
Mus musculus

Also known as CAK; Crk4; Cdkn7; P39 Mo15; C230069N13

Gene ID: 12572 | Gene type: protein coding

About Cdk7

Chromosome 13: 100,839,139-100,867,447 reverse strand.GRCm39:CM001006.3

This gene has 5 transcripts (splice variants), 213 orthologues, 25 paralogues and is associated with 4 phenotypes. Ubiquitous expression in limb E14.5 (RPKM 5.1), placenta adult (RPKM 4.4) and 28 other tissues.

Summary

Enables protein kinase activity. Predicted to be involved in protein stabilization; regulation of transcription by RNA polymerase II; and transcription initiation from RNA polymerase II promoter. Predicted to act upstream of or within DNA repair; cell division; and phosphorylation. Located in nucleus. Is expressed in embryo and future hindbrain. Orthologous to human CDK7 (cyclin dependent kinase 7). [provided by Alliance of Genome Resources, Apr 2022]

Cdk7 Products(1)

mRNA Protein Name
NM_009874.4 NP_034004.2 cyclin-dependent kinase 7

Cdk7 Protein Structure

STKc_CDK7

STKc_CDK7: cd07841 (10 - 307)

  • 0
  • 100
  • 200
  • 300
  • 346 a.a.
Protein Preferred Names Protein Names

cyclin-dependent kinase 7

39 kDa protein kinase

CDK-activating kinase

CR4 protein kinase

CRK4 PK (CDC2-related-kinase-4 protein kinase)

TFIIH basal transcription factor complex kinase subunit

cell division protein kinase 7

cyclin-dependent kinase 7 (homolog of Xenopus MO15 cdk-activating kinase)

protein-tyrosine kinase MPK-7

Related Agents

Approval
Bioactive Molecules (2)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-16297A Abemaciclib Inhibitor 99.96% Yes
HY-16297 Abemaciclib methanesulfonate Inhibitor 99.95% Yes
Clinical Phase
Bioactive Molecules (17)
Cat. No. Product Name Effect
Purity Phase
HY-50940 AT7519 Inhibitor 99.76% Phase 2
HY-103712A Samuraciclib hydrochloride Inhibitor 99.98% Phase 2
HY-13914 Roniciclib Inhibitor 98.03% Phase 2
HY-10424 Milciclib Inhibitor 99.90% Phase 2
HY-112272A Lerociclib dihydrochloride Inhibitor 98.11% Phase 2
HY-103712B Samuraciclib hydrochloride hydrate Inhibitor 99.08% Phase 2
HY-50943 AT7519 Hydrochloride Inhibitor 99.42% Phase 2
HY-112272 Lerociclib Inhibitor / Phase 2
HY-138293 SY-5609 Inhibitor 99.66% Phase 1
HY-10008 SNS-032 Inhibitor 99.51% Phase 1
HY-10012 AZD-5438 Inhibitor 99.85% Phase 1
HY-128587 Mevociclib Inhibitor 99.27% Phase 1
HY-11001 PHA-793887 Inhibitor 99.25% Phase 1
HY-15504 RGB-286638 Inhibitor 99.84% Phase 1
HY-15504A RGB-286638 free base Inhibitor 98.87% Phase 1
HY-50940A AT7519 TFA Inhibitor 98.53% Phase 1
HY-139342 CDK7-IN-4 Inhibitor / Phase 1
Pre-clinical Phase
Bioactive Molecules (58)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-80013 THZ1 Inhibitor 99.84% Unkown
HY-103618 THZ531 Inhibitor 99.86% Unkown
HY-103248 Toyocamycin Inhibitor 99.90% Unkown
HY-101257 YKL-5-124 Inhibitor 98.79% Unkown
HY-11009 CGP60474 Inhibitor 99.23% Unkown
HY-123954 Casein Kinase inhibitor A51 Inhibitor 98.58% Unkown
HY-10014 R547 Inhibitor 99.57% Unkown
HY-18340 (R)​-​CR8 Inhibitor 99.21% Unkown
HY-80013A THZ1 Hydrochloride Inhibitor 98.78% Unkown
HY-13266A BS-181 hydrochloride Inhibitor 99.80% Unkown
HY-12445 Asnuciclib Inhibitor 99.76% Unkown
HY-18340A (R)-CR8 trihydrochloride Inhibitor 98.95% Unkown
HY-X0150 JSH-150 Inhibitor 98.36% Unkown
HY-12653 LDC4297 Inhibitor 98.25% Unkown
HY-112626 CDK12-IN-2 Inhibitor 99.44% Unkown
HY-12293 LY2857785 Inhibitor 99.92% Unkown
HY-117203A CDK12-IN-E9 Inhibitor 99.97% Unkown
HY-119940 MC180295 Inhibitor 98.89% Unkown
HY-12280 THZ2 Inhibitor 99.03% Unkown
HY-144117 GFB-12811 Inhibitor 98.00% Unkown
HY-101257B YKL-5-124 TFA Inhibitor 99.44% Unkown
HY-107419 NU6140 Inhibitor 99.07% Unkown
HY-15241 NVP-LCQ195 Inhibitor 98.91% Unkown
HY-N6954 Garcinone C Inhibitor 99.66% Unkown
HY-123955 Casein Kinase inhibitor A86 Inhibitor 98.47% Unkown
HY-103712C Samuraciclib hydrochloride hydrate Inhibitor 99.88% Unkown
HY-18285 Longdaysin Inhibitor 99.87% Unkown
HY-19988 THZ1-R Inhibitor 98.12% Unkown
HY-12653A LDC4297 hydrochloride Inhibitor 98.25% Unkown
HY-100429 CAN508 Inhibitor 99.59% Unkown
HY-122665 HTH-01-091 Inhibitor 98.64% Unkown
HY-139980 CDK9-IN-13 Inhibitor 99.22% Unkown
HY-153278 CDK7-IN-21 Degrader 95.12% Unkown
HY-13266 BS-181 Inhibitor 98.10% Unkown
HY-139011 IV-361 Inhibitor 98.64% Unkown
HY-14372 BS-194 Inhibitor 99.36% Unkown
HY-136711 CDK7-IN-2 hydrochloride hydrate Inhibitor / Unkown
HY-103712 Samuraciclib Inhibitor / Unkown
HY-110368 BS-181 dihydrochloride Inhibitor / Unkown
HY-145655 CDK7-IN-11 Inhibitor / Unkown
HY-155787 SHR5428 Inhibitor / Unkown
HY-145402 CDK7-IN-7 Inhibitor / Unkown
HY-161463 CDK2-IN-28 Inhibitor / Unkown
HY-142696 CDK6/PIM1-IN-1 Inhibitor / Unkown
HY-145408 CDK7/9-IN-1 Inhibitor / Unkown
HY-143586 CDK7-IN-8 Inhibitor / Unkown
HY-147601 CDK7-IN-16 Inhibitor / Unkown
HY-116871 YKL-1-116 Inhibitor / Unkown
HY-139986 CDK7-IN-5 Inhibitor / Unkown
HY-145394 CDK7-IN-6 Inhibitor / Unkown
HY-145389 SZ-015268 Inhibitor / Unkown
HY-162416 CDK7-IN-27 Inhibitor / Unkown
HY-151878 CDK7-IN-20 Inhibitor / Unkown
HY-156444 HDAC1/CDK7-IN-1 Inhibitor / Unkown
HY-147409 Ulecaciclib Inhibitor / Unkown
HY-145424 CDK7-IN-10 Inhibitor / Unkown
HY-146276 CDK/HDAC-IN-2 Inhibitor / Unkown
HY-151898 CDK4/6-IN-14 Inhibitor / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens Cdk7 NCBI NCBI:1022